Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia
This study has been completed.
Study NCT01035671 Information provided by Penwest Pharmaceuticals Co.
First Received on December 17, 2009. Last Updated on April 21, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Friedreich's Ataxia
Additional conditions recognized in this trial
Ataxia
Friedreich Ataxia
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Cerebellar Diseases
Dyskinesias
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Metabolic Diseases
Mitochondrial Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neurologic Manifestations
Signs and Symptoms
Spinal Cord Diseases
Spinocerebellar Degenerations
Interventions listed in this trial
alpha-tocopherolquinone (A0001)
placebo
Additional drug interventions recognized in this trial
Tocopherylquinone
Vitamin E
More general drug interventions related to this trial
Anticoagulants
Antihypertensive Agents
Antioxidants
Cardiovascular Agents
Growth Substances
Hematologic Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Vitamins
Sponsors listed in this trial
Penwest Pharmaceuticals Co.
Back to top of Main Content
